Company intelligence
Cardiac Dimensions
Reshaping the Course of Heart Failure®
About Cardiac Dimensions
Cardiac Dimensions is reimagining the solutions available to patients suffering from heart failure (HF) by providing a therapy which allows patients to live longer, higher quality lives. Our product, the Carillon Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat patients with mitral valve insufficiency in a safe and effective manner. The Carillon therapy is the only indirect, no-touch mitral valve repair option designed to produce an annuloplasty effect while initiating left ventricular remodeling and improving long-term survival for patients. The Carillon therapy can also be used alongside other HF treatments should they be needed. Learn more about this proven solution for HF patients that uniquely treats the underlying causes—not symptoms—of mitral insufficiency at the website link below.
Verified activity
Signals from Cardiac Dimensions
4 published signals
Presence & Recognition
Cardiac Dimensions welcomed the team from Università degli Studi di Napoli Federico II (UniNa) and University of Naples Federico II to the EMPOWER family for the first ever randomization trial in Italy.
Reported by Cardiac Dimensions
Research & Knowledge
Cardiac Dimensions reported that the landmark EMPOWER Trial received yet another randomization from South Denver Cardiology Associates.
Reported by Cardiac Dimensions
Research & Knowledge
Cardiac Dimensions reported that Hillcrest HealthCare System (Oklahoma Heart Institute) continued their support of the EMPOWER Trial with yet another randomization.
Reported by Cardiac Dimensions
Research & Knowledge
Cardiac Dimensions supported the EMPOWER Trial at Carilion Clinic with another randomization.
Reported by Cardiac Dimensions